vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and PEDEVCO CORP (PED). Click either name above to swap in a different company.

PEDEVCO CORP is the larger business by last-quarter revenue ($23.1M vs $19.2M, roughly 1.2× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -36.8%, a 17.1% gap on every dollar of revenue. On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs 35.8%). Over the past eight quarters, PEDEVCO CORP's revenue compounded faster (68.6% CAGR vs 26.5%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

CURI vs PED — Head-to-Head

Bigger by revenue
PED
PED
1.2× larger
PED
$23.1M
$19.2M
CURI
Growing faster (revenue YoY)
PED
PED
+82.4% gap
PED
118.2%
35.8%
CURI
Higher net margin
CURI
CURI
17.1% more per $
CURI
-19.7%
-36.8%
PED
Faster 2-yr revenue CAGR
PED
PED
Annualised
PED
68.6%
26.5%
CURI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
PED
PED
Revenue
$19.2M
$23.1M
Net Profit
$-3.8M
$-8.5M
Gross Margin
Operating Margin
-17.6%
-21.3%
Net Margin
-19.7%
-36.8%
Revenue YoY
35.8%
118.2%
Net Profit YoY
-34.6%
-243.5%
EPS (diluted)
$-0.07
$-2.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
PED
PED
Q4 25
$19.2M
$23.1M
Q3 25
$18.4M
$7.0M
Q2 25
$19.0M
$7.0M
Q1 25
$15.1M
$8.7M
Q4 24
$14.1M
$10.6M
Q3 24
$12.6M
$9.1M
Q2 24
$12.4M
$11.8M
Q1 24
$12.0M
$8.1M
Net Profit
CURI
CURI
PED
PED
Q4 25
$-3.8M
$-8.5M
Q3 25
$-3.7M
$-325.0K
Q2 25
$784.0K
$-1.7M
Q1 25
$319.0K
$140.0K
Q4 24
$-2.8M
$5.9M
Q3 24
$-3.1M
$2.9M
Q2 24
$-2.0M
$2.7M
Q1 24
$-5.0M
$773.0K
Operating Margin
CURI
CURI
PED
PED
Q4 25
-17.6%
-21.3%
Q3 25
-24.5%
-12.0%
Q2 25
2.5%
-32.2%
Q1 25
0.5%
1.7%
Q4 24
-27.4%
-12.9%
Q3 24
-25.8%
31.3%
Q2 24
-20.6%
22.3%
Q1 24
-30.4%
7.6%
Net Margin
CURI
CURI
PED
PED
Q4 25
-19.7%
-36.8%
Q3 25
-20.4%
-4.7%
Q2 25
4.1%
-24.0%
Q1 25
2.1%
1.6%
Q4 24
-19.9%
56.0%
Q3 24
-24.3%
32.2%
Q2 24
-16.4%
22.7%
Q1 24
-42.0%
9.5%
EPS (diluted)
CURI
CURI
PED
PED
Q4 25
$-0.07
$-2.23
Q3 25
$-0.06
$0.00
Q2 25
$0.01
$-0.02
Q1 25
$0.01
$0.00
Q4 24
$-0.05
$2.69
Q3 24
$-0.06
$0.03
Q2 24
$-0.04
$0.03
Q1 24
$-0.09
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
PED
PED
Cash + ST InvestmentsLiquidity on hand
$27.3M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$207.4M
Total Assets
$75.7M
$375.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
PED
PED
Q4 25
$27.3M
$3.2M
Q3 25
$27.8M
$10.9M
Q2 25
$28.1M
$8.5M
Q1 25
$33.4M
$10.4M
Q4 24
$32.1M
$4.0M
Q3 24
$33.2M
$4.6M
Q2 24
$39.5M
$6.1M
Q1 24
$38.8M
$13.3M
Stockholders' Equity
CURI
CURI
PED
PED
Q4 25
$41.5M
$207.4M
Q3 25
$47.2M
$115.4M
Q2 25
$49.8M
$115.2M
Q1 25
$58.1M
$116.2M
Q4 24
$57.8M
$115.6M
Q3 24
$62.2M
$106.5M
Q2 24
$64.8M
$103.2M
Q1 24
$67.0M
$100.0M
Total Assets
CURI
CURI
PED
PED
Q4 25
$75.7M
$375.9M
Q3 25
$74.7M
$135.9M
Q2 25
$78.7M
$136.8M
Q1 25
$85.3M
$145.6M
Q4 24
$86.2M
$128.3M
Q3 24
$87.6M
$114.3M
Q2 24
$90.9M
$111.0M
Q1 24
$94.6M
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
PED
PED
Operating Cash FlowLast quarter
$4.0M
$-2.1M
Free Cash FlowOCF − Capex
$3.9M
FCF MarginFCF / Revenue
20.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
PED
PED
Q4 25
$4.0M
$-2.1M
Q3 25
$4.4M
$7.4M
Q2 25
$2.8M
$-420.0K
Q1 25
$1.9M
$5.9M
Q4 24
$3.0M
$4.2M
Q3 24
$2.3M
$8.3M
Q2 24
$2.2M
$4.6M
Q1 24
$666.0K
$-4.3M
Free Cash Flow
CURI
CURI
PED
PED
Q4 25
$3.9M
Q3 25
Q2 25
Q1 25
$1.8M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
CURI
CURI
PED
PED
Q4 25
20.5%
Q3 25
Q2 25
Q1 25
12.2%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CURI
CURI
PED
PED
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.5%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
CURI
CURI
PED
PED
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
42.34×
Q4 24
0.71×
Q3 24
2.83×
Q2 24
1.71×
Q1 24
-5.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons